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Abstract
Background: Various options exist for collecting biospecimens and biomarkers from cohort study participants, and
these have important logistic, resource and scientific implications. Evidence on how different collection methods
affect participation and data quality is lacking. This parallel-design randomised trial, the Link-Up Study, involved
blood sample donation and other data collection among participants in an existing cohort study, The 45 and Up
Study. It aimed to investigate the relation of fasting status, reminder letters and data collection site to response
rates, data quality and biospecimen yield.
Methods: Individuals aged 45 and over participating in The 45 and Up Study and living ≤20 km from central
Wagga Wagga, NSW (regional area) or ≤10 km from central Parramatta, NSW (urban area) (n = 2340) were
randomised, stratified by area of residence, to be invited to give a blood sample and additional data by attending
either a clinic established specifically for the trial, with an appointment time (“dedicated clinic”, n = 1336) or an
existing local commercial pathology centre (n = 1004). Within dedicated clinic groups, participants were randomised
into fasting (n = 668) or non-fasting (n = 668) and, at the Parramatta pathology centre site, reminder letter after two
weeks (n = 336) or no reminder (n = 334).
Results: Overall, 33% (762/2340) of invitees took part in the Link-Up Study; 41% (410/1002) among regional and
26% (352/1338) among urban-area residents (p < 0.0001). At the dedicated clinics, response rates were 38%
(257/668) not fasting and 38% fasting (257/668) (participation rate ratio (RR) = 1.00, 95%CI 0.91-1.08, p = 0.98). The
response rate was 22% among individuals randomised to attend the Parramatta pathology centre without a
reminder and 23% among those sent a reminder letter (RR = 1.01, 0.93-1.09, p = 0.74). In total, the response rate was
38% (514/1336) at the dedicated clinics and 25% (248/1004) at the pathology centres (RR = 0.67, 0.56-0.78, p < 0.01);
measures of height, weight and systolic and diastolic blood pressure did not vary materially between these groups,
nor did the median number of aliquots of plasma, buffy coat and red cells collected.
Conclusions: Among cohort study participants, response rates for an additional study involving biospecimen
collection, but not data quality or average biospecimen yield, were considerably higher at dedicated clinics than at
existing commercial pathology sites.
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Background
Large-scale prospective studies have contributed enor-
mously to our understanding of health. Increasingly,
such large scale studies include the collection of biospe-
cimens, to allow investigation and integration of genetic
and other biomarker data within epidemiological re-
search. There are multiple possible methods for the col-
lection of biospecimens, ranging from in-home
collection, use of mobile vans, attendance at a facility
set up specifically for the purpose (termed here a “dedi-
cated clinic”) [1], to use of existing health care facilities
[2]. The choice of collection method has important logis-
tic, resource and scientific implications. However, empir-
ical evidence regarding the impact of different
biospecimen collection methods on measures such as re-
sponse rate and data quality is lacking.
This paper describes a randomised trial in Australia,
comparing biospecimen and biomarker data collection
(including physical measures) through dedicated clinics,
set up specifically for the trial, with collection through
existing commercial pathology centres. Specifically, the
trial aimed to compare the response rate to an invitation
to give a blood sample and have physical measurements
(height, weight, blood pressure and heart rate) taken and
the data quality and biospecimen yield, among existing
participants from a population-based cohort study (The
45 and Up Study), in individuals randomised to:
1. Whether the participant was asked to attend fasting
or not fasting;
2. Whether or not a reminder letter was sent to non-
attending participants and;
3. Different sites of data collection (dedicated clinic
versus an existing commercial pathology centre);
Methods
Study population
The “Link-Up Study” was conducted among a subset of
2340 individuals already taking part in The 45 and Up
Study, a large scale study of healthy ageing of men
and women aged 45 years and over from the general
population of New South Wales, Australia. A total of
266,848 participants joined The 45 and Up Study be-
tween February 2006 and November 2008 by completing
a postal questionnaire and providing written consent for
long term follow-up of their health, including linkage to
routinely collected population databases of health infor-
mation. The 45 and Up Study is described in detail else-
where [3].
Data collection centres
An urban and a regional location were selected for this
randomised trial, to allow comparison of response rates in
these two types of location. The locations of Parramatta,
New South Wales (urban) and Wagga Wagga, New South
Wales (regional) were chosen on the basis of having over
1000 45 and Up Study participants resident in the target
area, being fairly typical of urban and regional areas in
New South Wales and having a local pathology centre. At
each location, two collection sites were established; a dedi-
cated clinic was set up de novo and a suitable commercial
pathology centre was identified, with 4 collection sites
established in total.
Intervention
Eligible individuals were 45 and Up Study cohort mem-
bers, resident in Wagga Wagga or Parramatta. In total,
2340 eligible participants in the two areas were rando-
mised to be invited to attend either a commercial path-
ology centre or a dedicated clinic (see Randomisation
section below).
Eligible 45 and Up Study cohort members were sent a
postal invitation to take part in the Link-Up Study, which
included a covering letter from The 45 and Up Study, a
participant information leaflet and a brief questionnaire.
Participants randomised to the commercial pathology
arm also received a Pathology Request Form, which pro-
vided collection instructions for the phlebotomist (quan-
tity, preservative etc.); the participant was asked to bring
this form with them when they attended the pathology
collection centre.
Self-administered questionnaire and consent
Participants were instructed to complete the question-
naire prior to attending their designated collection site
and return it when they attended to give a blood sample.
The questionnaire was one A4 page, and repeated
selected questions from The 45 and Up Study baseline
questionnaire. Questions included the participant’s date
of birth, self reported height and weight, self-rated
health, health events in the last 3 years, and the Medical
Outcomes Score Physical Functioning scale.
The consent form was on the reverse of the question-
naire. Participants gave consent for the collection, long-
term storage and use of their blood sample for unspecified
health research, including genetic research. Participants
gave their consent on the understanding that they would
not receive any results from tests on their blood sample.
Additionally, participants agreed to their questionnaire
answers and biomarker data being combined with the
health information that was already part of The 45 and
Up Study, including linkage to various population data-
bases [3].
Dedicated clinics
The dedicated clinics for this trial were set up in a Police,
Citizens, Youth Club in Wagga Wagga and a Returned
and Services League club in Parramatta, using methods
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previously employed in a population-based survey study
of diabetes and related risk factors [4]. These sites were
chosen as they were familiar to the local community and
easily accessible. Each location was staffed by a project
manager, three casual field staff and a phlebotomist, who
were all specifically trained to take the measurements and
samples in accordance with the study protocol.
Potential participants randomised to attend a dedicated
clinic were given a provisional appointment time in their
invitation letter, which they could change if required.
Individuals randomised to attend fasting were provided
with fasting instructions (i.e. no food or drink for
10 hours prior to their appointment, except for water).
All fasting appointments were made in the morning to
minimise the risk of ill effects and inconvenience to the
participant. Clinic staff phoned participants 1–2 days
prior to the scheduled appointment to confirm the parti-
cipant’s attendance. Where a participant was unable to
make the scheduled appointment, clinic staff followed-
up the participant by phone to reschedule the appoint-
ment. Participants were able to attend the dedicated
clinics from Sunday to Thursday.
Commercial pathology centres
The commercial pathology arm utilised the existing infra-
structure of a commercial pathology service with a net-
work of collection centres covering much of New South
Wales. Collection of blood samples was undertaken by
existing pathology centre staff who were specifically
trained by Link-Up Study staff to measure height, weight,
waist circumference, blood pressure and heart rate. While
each pathology collection centre has its own anthropo-
metric measurement equipment, for consistency the same
measurement equipment used in the dedicated clinic arm
was supplied for use in the pathology arm. Participants
were otherwise able to make use of the existing facilities
at these centres (e.g. waiting rooms, phlebotomy chairs,
vaccutainers).
The pathology centres are attended by general patients
as well as trial participants. Due to the existing workload
from fasting general patients, the commercial pathology
centres were not able to guarantee that fasting trial parti-
cipants would be able to be seen in the morning. For this
reason, fasting samples were not collected in the path-
ology centre arm of the trial.
Appointments were not given to participants in the
pathology arm. Instead, participants were able to attend
at a time convenient to them within a specified 4 week
date range. Participants were able to attend the commer-
cial pathology from Monday to Thursday. Potential par-
ticipants randomised to the reminder arm were sent a
second invitation 2 weeks after the initial invitation, if
they had not attended by that date.
Measurement of height, weight, waist circumference, blood
pressure and heart rate
Height was measured using a Charder HM200P stadi-
ometer and was recorded to the nearest 0.1 cm. Partici-
pants were instructed to remove their shoes, stand up
straight with weight evenly distributed on both feet and
position their head so that the line of vision was at
right angles to the body. The measurement was taken
as the participant inhaled deeply and stretched to their
fullest height.
Weight was measured using a Charder MS-3200
digital scale and was recorded to the nearest 0.1 kg.
Participants were measured in light clothing and with-
out shoes. Participants were instructed to stand over
the centre of the scales with their weight distributed
evenly on both feet.
Waist circumference was measured using a Seca 203
waist circumference measuring tape. Participants were
instructed to remove any items such as belts or bulky
clothing that would interfere with the measurement.
Measurements were taken with the participant standing
with their feet separated between 25–30 cm and weight
distributed evenly on both feet. The tape was positioned
on the participant’s waist and the measurement was
taken at expiration.
Blood pressure and heart rate were measured using an
Omron Digital Automatic Blood Pressure Monitor HEM-
907. Participants were instructed to remove any bulky
items of clothing around their arms. Prior to the measure-
ments being taken, the participant sat still for 5 minutes
with their legs uncrossed and feet flat on the ground.
Blood specimen collection and processing for storage
The phlebotomists at each site took a 30 ml blood sam-
ple from participants. The sample was collected into
tubes as follows:
(i) 3 x 6 ml Ethylenediaminetetraacetic (EDTA);
(ii) 1 x 6 ml Acid-citrate-dextrose (ACD); and
(iii) 1 x 6 ml Lithium Heparin (LiHep).
Immediately following collection each tube was la-
belled with the date and time of collection, the partici-
pant’s date of birth, sex and their unique trial ID
number. Samples were refrigerated at 4°C prior to
and during transportation to the central laboratory at
Darlinghurst, New South Wales. Samples were trans-
ported to the laboratory within 36 hours of collection
and were processed within 48 hours.
Samples were centrifuged at 2500 rpm for 10 minutes
at room temperature. Plasma was removed using a
transfer pipette and 0.5 ml aliquotted into 1.0 ml cryo
tubes. Buffy coat was then removed into 1.0 ml cryo
tubes. One 0.5 ml aliquot of red cells was removed from
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one of the EDTA tubes, with a transfer pipette into one
1.0 ml cryo tube. Processing generally yielded a total of
22 aliquots for each 30 ml sample (16 plasma, 5 buffy
coat, 1 red cells). Once processed, the samples were fro-
zen at −80°C in ultra low temperature freezers.
Randomisation
A total of 2340 individuals who had provided an address
in either Wagga Wagga or Parramatta were randomly
sampled from The 45 and Up Study cohort and invited
by post to participate in the Link-Up Study (Figure 1).
Mailing of invitations began on 25 June 2009, with data
collection from 5 July 2009 to 6 August 2009 in Wagga
Wagga and from 16 August 2009 to 24 September 2009
in Parramatta.
The addresses of 45 and Up Study participants have
been geocoded using the geocoding system in Freely Ex-
tensible Biomedical Record Linkage (FEBRL) [5]. The
General Post Office (GPO) was selected as the central
area at each location and distance from the central area
was calculated using the great-circle distance formula.
Participants with a residential address geocoded to the
street level, and within 10 km of Parramatta GPO
(33.81S, 151.00E) or 20 km of Wagga GPO (35.10S,
147.37E) were selected into the sampling frame. A strati-
fied sample of potential participants was drawn randomly
(using a computer generated randomisation list) in each
area, with stratification by distance from the GPO.
In Wagga Wagga, 1002 participants were selected,
stratified by distance (0-5 km from GPO, 5-20 km from
GPO) with equal allocation into each stratification group.
In Parramatta 1002 participants were initially selected,
stratified by distance from Parramatta GPO (0-5 km from
GPO, 5-10 km from GPO).
From the samples in each area, participants were ran-
domly allocated in equal proportions to one of three
groups (using a computer generated randomisation list):
(i) invited to attend the dedicated clinic, not fasting;
(ii) invited to attend the dedicated clinic, fasting; and
(iii) invited to attend the pathology centre, not fasting,
no reminder letter.
After preliminary results of relatively low response rates
were available from Wagga Wagga, a decision was made
to include a fourth group in the trial in Parramatta:
invited to attend the pathology centre, not fasting, with
reminder letter. An additional 336 eligible participants in
the Parramatta area that had not already been selected
for sampling were randomly selected (using a computer
generated randomisation list) and allocated to this add-
itional pathology arm.
KDR was responsible for generating the syntax used to
randomly sample and allocate participants to treatment
groups. Randomisation and stratification processes are
summarised in Figure 1.
Blinding
Although invitees were told in the study information
leaflet that they were part of a pilot project and that
their participation would assist “in deciding the best way
of implementing the Link-Up Project”, they were not
aware of the trial hypotheses or randomisation to differ-
ing data collection site types, fasting status and re-
minder letter receipt. In analysing and interpreting the
Stratification by 
location
0-<5km, 5-<20km
Dedicated Clinic 
Without Fasting
n = 334
Randomisation
Dedicated Clinic
With Fasting 
n = 334
Pathology 
Centre
n = 334
Regional
n = 1002
Pathology 
Centre
Reminder
n = 336
Stratification by 
location
0-<5km, 5-<10km
Randomisation
Urban
n = 1338
Dedicated Clinic 
Without Fasting
n = 334
Dedicated Clinic
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n = 334
Pathology 
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No Reminder
n = 334
Figure 1 Protocol for allocation of study participants to groups.
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data, the authors were aware of the randomisation status
of study participants.
Outcome measures
The primary outcome measure for this trial is partici-
pation in the Link-Up Study, through attendance at a
biospecimen collection site to provide a blood sample
and giving written consent to participate, including
use of blood samples for genetic and other research.
The proportion of invitees who went on to participate
in this way in the Link-Up Study is termed the “re-
sponse rate”.
Concern is often expressed that dedicated clinics and
highly trained study staff are necessary to make physical
measurements for cohort studies and that staff from
health services may not be capable of taking measure-
ments in the same way. Among individuals who went
on to participate in the Link-Up Study, the biospecimen
yield and features of the biomarker data (height, weight,
heart rate and systolic and diastolic blood pressure)
were compared for those attending the dedicated clinic
and those attending the pathology centre, in order to in-
vestigate whether there was any empirical evidence of
systematic differences that might indicate issues with
data quality.
Statistical methods
We estimated we would need 668 participants in each
treatment group across the area, based on an initially esti-
mated response rate of 50% and difference in response
rate of 7.6% between treatment groups for power of 0.796.
We allocated ~334 persons to each area and planned to
pool across areas to compare treatment effects of data col-
lection type (pathology vs. dedicated clinic).
Data from the participants’ 45 and Up Study baseline
questionnaire were added to the data on responses and
clinical data from the Link-Up Study. Information from
the Link-Up Study included: area (Wagga Wagga or
Parramatta); distance from GPO (categorised as <5 km
and >5 km); and the trial group that the participant was
allocated to. Distance from GPO was based on the most
current residential address held by The 45 and Up Study.
Response rate was analysed using a log binomial model
(proc genmod in SAS, v9.2 Cary NC, USA) with re-
sponse (yes or no) as the outcome, and randomisation
group as the predictor variable. Associations with expos-
ure variables were expressed as a participation rate ratio
(RR). Quantifying differences in response rate between
randomisation groups, stratified by area. Linear combi-
nations of coefficients were used to test three specific hy-
potheses about differences in response rates between:
(i) fasting versus non-fasting groups in dedicated
clinics;
(ii) reminder versus no reminder, for specimens
collected at the pathology service at Parramatta
only;
(iii) dedicated clinic versus pathology service.
Wald 95% confidence intervals were calculated for rate
ratio estimates.
Among those participating in the Link-Up Study, the
means, standard deviations and differences between self-
reported and measured height and weight and measured
blood pressure were compared between dedicated clinic
and pathology service, within each area, using standard
t-tests and Bland-Altman plots. Biospecimen yields
were measured according to the number of aliquots of
plasma, buffy coat and red cells in each preservative
type, and compared with pre-specified targets for each
of these biospecimens and also compared between the
different collection sites, using standard t-tests.
We have not made a formal correction (e.g. Bonferonni
correction) for multiple testing (multiple treatment
comparison and multiple outcomes) in our study. We
have calculated five p-values for the main outcome (re-
sponse rate), 14 p-values for measurement differences,
and 16 p-values for blood aliquot yield. The chance of a
Type I error increases with the number of tests per-
formed, so our results should be interpreted with the
number of tests for each outcome in mind.
Ethical approval for the study was provided by
the University of New South Wales, Human Research
Ethics Committee, the Australian National University
Human Research Ethics Committee, and the University
of Western Sydney Human Research Ethics Committee.
Results
Baseline characteristics according to randomisation group
Table 1 shows a range of demographic, lifestyle and
other characteristics of the trial participants according to
the group they were randomised to. There were no
marked differences between the groups, in either urban
or regional strata.
Overall response to the invitation to participate
The overall uptake of the invitation to participate in the
Link-Up Study was 33% (762/2340). The response rate
was 41% (410/1002) among participants resident in the
regional area (Wagga Wagga) and 26% (352/1338)
among those resident in the urban area (Parramatta)
(p < 0.0001).
Response rate according to whether participants were
invited to attend fasting or not fasting
Individuals invited to provide biospecimens and physical
measures at the dedicated clinics were randomly allo-
cated to be invited fasting or not fasting. In Wagga
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Wagga, a total of 46% of those randomised to attend the
clinic in a non-fasting state attended their appointment,
compared to 47% randomised to fasting (participation
rate ratio, RR fasting versus non-fasting = 1.01, 95% CI
0.91-1.11, p = 0.87; Table 2). Figures for non-fasting and
fasting at Parramatta were 31% and 30%, respectively.
(RR = 0.99, 95%CI 0.86-1.13), p = 0.88; Table 2). Combin-
ing the dedicated clinic in both areas, the response rate
was 38% (257/668) not fasting and 38% fasting (257/668)
(RR= 1.00, 95%CI 0.91-1.08, p = 0.98).
Response rate according to whether or not participants
received a reminder letter
Participants invited to attend the Wagga Wagga pathology
centre did not receive a reminder letter. Individuals invited
to attend the Parramatta pathology centre were randomised
to either receive or not receive a reminder letter, if they had
not responded to their initial invitation in the first two
weeks of data collection. The response rate was 22% among
individuals randomised to attend the Parramatta pathology
service without a reminder and 23% among those who
were sent a reminder letter (RR reminder versus no re-
minder =1.01, 95% CI 0.93-1.09, p =0.74).
Response rate according to whether participants were
invited to attend a dedicated clinic or commercial
pathology centre
In Wagga Wagga, the response rate was 46% among
those randomised to attend the dedicated clinic, not fast-
ing and 30% among those randomised to attend the
pathology centre, not fasting (RR= 0.64, 95% CI 1.0.53-
0.79, p < 0.01; Table 2). In Parramatta, the response rate
Table 1 Participant characteristic by area and randomisation status
Wagga Wagga
Randomised to:
Group 1
Dedicated clinic not fasting
Group 2
Dedicated clinic fasting
Group 3
Pathology centre not fasting no reminder
Total (N) 334 334 334
Age (mean [SD]) 60.8 [9.7] 61.6 [10.5] 60.7 [10.3]
Sex (% male) 47.6 45.5 40.7
Distance from centre
(mean km [SD])
5.0 [2.9] 5.0 [3.3] 5.2 [3.3]
Work status (% full time paid work) 31.1 29.6 33.2
Time since recruitment (% >1 year) 48.5 52.1 52.1
Education (% tertiary educated) 22.9 24.7 19.7
Carer status (% full time carer) 3.6 3.0 4.5
Disability (% major disability) 3.8 7.3 4.9
Physical function (% severe
limitation)
11.8 14.5 14.7
Smoking (% current smokers) 7.5 5.5 6.6
BMI (% obese (BMI≥ 30 kgm-2)) 27.1 23.5 30.2
Parramatta
Randomised to:
Group 1
Dedicated clinic not fasting
Group 2
Dedicated clinic fasting
Group 3
Pathology centre not
fasting no reminder
Group 4
Pathology centre not
fasting with reminder
Total (N) 334 334 334 336
Age (mean [SD]) 64.2 [12.0] 63.1 [12.7] 64.1 [11.8] 63.5 [11.2]
Sex (% male) 47.6 49.7 50.6 49.4
Distance from centre
(mean km [SD])
5.7 [2.4] 5.7 [2.6] 5.7 [2.5] 5.8 [2.5]
Work status (% full time paid work) 28.7 31.8 28.2 29.6
Time since recruitment
(% >1 year)
53.1 47.7 54.2 55.1
Education (% tertiary educated) 28.3 25.7 25.6 23.1
Carer status (% full time carer) 3.3 4.5 5.1 4.2
Disability (% major disability) 10.5 5.9 4.0 6.6
Physical function (% severe
limitation)
18.6 17.8 18.4 21.1
Smoking (% current smokers) 7.3 8.4 6.9 5.7
BMI (% obese (BMI≥ 30 kgm-2)) 24.9 22.5 21.8 22.3
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for those randomised to attend the dedicated clinic not
fasting was 31% compared to 22% among those rando-
mised to attend the pathology centre not fasting, with
no reminder (RR= 0.69, 95% CI 0.53-0.90, p < 0.01).
Combining the regional and urban areas, the fasting and
non-fasting participants and those who did and did not
receive a reminder letter, the overall response rate was
38% (514/1336) at the dedicated clinics and 25% (248/
1004) at the pathology centres (RR= 0.67, 95% CI 0.56-
0.78, p < 0.01).
For the randomised elements of this study relating to
fasting status and the reminder letter, a meaningful dif-
ference in the RR can effectively be ruled out, since they
are estimated with high precision. Hence, there is little
evidence for large differences in these RR.
Physical measures and biospecimen yields at dedicated
clinics and commercial pathology centres
Mean height, weight and systolic blood pressure did not
differ significantly between the dedicated clinics and
commercial pathology centres in either the regional or
urban areas (Table 3). Diastolic blood pressure was sig-
nificantly higher at the Wagga Wagga pathology centre
than at the dedicated clinic (p < 0.01), but did not differ
significantly between the two types of collection sites in
Parramatta. The differences between measured height
and weight, and self-reported height and weight on the
brief questionnaire completed prior to measurement,
were similar across all four sites. Bland-Altman plots
suggested no large or systematic variation in the differ-
ences between self-reported and measured height and
weight according to the type of data collection site (data
not shown).
Median biospecimen yields and 5th centiles were
within one aliquot of the target for each type of sample
fraction, preservative and biospecimen collection site, ex-
cept for the 5th centile at the Wagga Wagga dedicated
clinic for EDTA- and Lithium-Heparin-plasma (Table 4).
No systematic variation in yield between the dedicated
clinics and pathology centres could be identified.
Adverse events
One episode of fainting occurred in a fasting partici-
pant at the Wagga Wagga dedicated clinic. This partici-
pant had done a number of hours of hard physical
work before attending the collection site. No other ad-
verse events were observed.
Discussion
The collection of biospecimens and biomakers is in-
creasingly recognised as an important component of
large scale epidemiological research. Such data enhance
substantially the range and nature of the research ques-
tions that can be addressed and allow joint consideration
of environmental and genetic factors. However, the es-
tablishment of large scale biobanks requires consider-
ation of pragmatic and cost factors, alongside traditional
scientific and methodological issues [6].
We found that a single mailed invitation to existing co-
hort study members to donate a blood sample, have
physical measurements taken and have these included in
a long term biobank for unspecified research purposes
yielded a substantial number of participants, with 33% of
those approached taking part. The randomised data indi-
cate that response rates were one-third lower at existing
commercial pathology centres than at collection sites
established specifically for the purpose of the study,
where potential participants were given specified ap-
pointment times and phone reminders to attend their
appointment. There was no significant difference in re-
sponse rates according to whether or not participants
were randomised to be invited to attend in a fasting or
non-fasting state or according to whether or not they
received a reminder letter. Those residing in regional
Table 2 Response rate to participation in the Link-Up Study among existing participants in The 45 and Up Study, by
area of residence and randomisation status
Group Total Participation rate ratio (RR) P (χ2 test)
N n (%) RR (95% CI)
Total 2340 762 (33%)
Wagga Wagga 1002
Group 1 Dedicated Clinic without fasting 334 154 (46%) 1.00
Group 2 Dedicated Clinic with fasting 334 156 (47%) 1.01 (0.91-1.11) Fasting vs. non fasting: p = 0.87
Group 3 Pathology Service no reminder 334 100 (30%) 0.64 (0.53-0.79) Clinic vs. pathology service: p <0.01
Parramatta 1338
Group 1 Dedicated Clinic without fasting 334 103 (31%) 1.00
Group 2 Dedicated Clinic with fasting 334 101 (30%) 0.99 (0.86-1.13) Fasting vs non fasting: p = 0.88
Group 3 Pathology Service no reminder 334 72 (22%) 0.69 (0.53-0.90) Clinic vs pathology service: p <0.01
Group 4 Pathology Service with reminder 336 76 (23%) 1.01 (0.93-1.09) Reminder vs no reminder: p = 0.74
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areas were more likely to participate than those in urban
areas. No systematic differences in data quality and bios-
pecimen yield were seen between the dedicated clinics
and pathology centres.
We are not aware of any other studies that have made
randomised comparisons of biobank participation rates
according to type of collection site, so the evidence to
date in this area is limited. There are several plausible
explanations for the higher attendance rates at dedicated
clinics. Studies researching the effect of invitation type
on attendance for breast and cervical cancer screening
have established that assigned appointments increased
uptake of screening [7–9] and this was the method of
choice for recruitment into the UK Biobank [1]. A phone
call reminder to follow up a written invitation is an add-
itional effective method of increasing participation
[10,11]. Furthermore, several studies have found that
establishing a separate clinic in general practice for
cancer screening and vaccinations is an effective way of
increasing response rates [8,12,13], however whether this
finding is generalisable to recruitment to biobanks is
unclear. The dedicated clinics were able to accommodate
weekend recruitment, which was not possible through the
pathology centres.
There is little research that can explain why people
may be willing to participate in a biobank in some situa-
tions, but not others. Previous studies indicate that mul-
tiple methods of contact with participants leads to
higher response rates in studies in general [10,11]. Other
studies have found that multiple reminders are an effect-
ive way of increasing response rates to postal question-
naires [14,15]. However, in the current trial, a single
reminder letter sent to half the cohort members rando-
mised to attend a pathology centre in Parramatta did
not have a significant effect on response rates. The rea-
son for this is not known; potential explanations include
the fact that only one reminder was given, that the re-
minder was also sent by mail, that study power was lim-
ited or that no genuine difference was present, in this
setting.
Research has previously been undertaken to investigate
whether individuals would be willing to participate in
biobanking, using hypothetical scenarios [16–19], how-
ever, data comparing the factors related to actual
Table 3 Comparison of height, weight, blood pressure and heart rate measurements at the dedicated clinics versus
pathology services
Area: Wagga Wagga
Measurement Dedicated clinic Pathology service p(Difference)
Mean
Height [cm (95% CI)] 168.3 (166.8-169.7) 166.0 (164.3-167.8) 0.710
Weight [kg (95% CI)] 80.2 (78.3-82.1) 76.8 (76.8-84.5) 0.807
Difference between
self-reported and measured:
Height [cm (95% CI)] 0.5 (0.2-0.9) 1.2 (0.5-2.1) 0.665
Weight [kg (95% CI)] −1.6 (−1.8- -1.3) −1.2 (−1.8- -0.6) 0.842
Mean
Systolic blood pressure [mmHg (95%CI)] 134.5 (132.6-136.4) 135.6 (131.3-140.1) 0.754
Diastolic blood pressure [mmHg (95%CI)] 75.5 (74.3-76.6) 80.1 (77.9-82.4) <0.01
Pulse rate [beats per minute (95% CI)] 69.5 (68.2-70.8) 71.8 (69.9-73.6) 0.078
Area: Parramatta
Measurement Dedicated clinic Pathology service p(Difference)
Mean
Height [cm (95% CI)] 166.9 (165.6-168.3) 166.7 (165.1-168.2) 0.808
Weight [kg (95% CI)] 78.6 (76.2-81.0) 77.5 (74.6-80.5) 0.567
Difference between
self-reported and measured:
Height [cm (95% CI)] 1.5 (1.1-1.9) 0.5 (0.1-1.1) 0.272
Weight [kg (95% CI)] −0.9 (−1.2- -0.5) −1.1 (−1.5- -0.7) 0.339
Mean
Systolic blood pressure [mmHg (95%CI)] 131.4 (128.9-134.0) 132.2 (129.3-135.0) 0.708
Diastolic blood pressure [mmHg (95%CI)] 76.6 (75.1-78.1) 75.5 (74.3-76.6) 0.312
Pulse rate [beats per minute (95% CI)] 71.5 (70.0-73.1) 69.5 (68.2-70.8) 0.619
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participation, are limited. The results from the present
trial indicated that response rates were higher amongst
participants in the regional area than in the urban area.
A large multicentre US study found that enrolment site
was the most important influence on consenting to do-
nate biospecimens, with response rates varying between
40% and 100% over the 24 enrolment sites used in the
study [20]. However, although it was noted that the sites
represented a diverse range of urban and regional areas,
the researchers did not indicate which locations yielded
higher response rates. In contrast, another biobank study
found no significant difference based on residential area,
however this study measured willingness to participate
and not actual participation [21].
There are a number of potential limitations of the
current trial that should be borne in mind. We used ad-
dress details from the baseline mailout for The 45 and
Up Study cohort, updated where participants notified
The 45 and Up Study Coordinating Centre of a change
of address. However, it is likely that some participants
had moved, without updating their address details, in
the one to three years since joining The 45 and Up
Study; others may not have received their invitation or
may have been unavailable to take part in the Link-Up
Study for some other reason (e.g. holidays, illness). Al-
though the randomised design means that this is un-
likely to bias the main comparisons, it does mean that
the response rate should be considered to be the pro-
portion of people taking part in the biobank as a pro-
portion of those sent invitations, not as a proportion of
those who actually received an invitation. The trial only
compared two models of biospecimen and physical
measurement data collection. It is therefore not possible
to separate different elements of the two designs. For
example, it is not possible to establish what the separate
contributions of the specific appointment time, weekend
Table 4 Comparison of number and types of aliquots collected at the dedicated clinics versus pathology services
Area: Wagga Wagga
Type of aliquot Target Dedicated clinic Pathology centre p(Difference)
number of aliquots median number of aliquots
(5th-95th centile)
median number of aliquots
(5th-95th centile)
median number of aliquots dedicated
clinic vs pathology centre
EDTA
Buffy coat 3 3 (2–3) 3 (3–3) 0.40
Plasma 10 12 (8–16) 12 (10–15) <0.01
Red cells 1 1 (1–1) 1 (1–1) 0.87
ACD
Buffy coat 1 1 (1 – 1) 1 (1–1) 0.74
Plasma 3 5 (2 – 6) 5 (4–6) <0.01
Li-Hep
Buffy coat 1 1 (1–1) 1 (1–1) 0.07
Plasma 3 4 (1–5) 4 (3–5) 0.01
Total 22 26 (18–33) 27 (24–31) <0.01
Area: Parramatta
Type of aliquot Target Dedicated clinic Pathology centre p(Difference)
number of aliquots median number of aliquots
(5th-95th centile)
median number of aliquots
(5th-95th centile)
median number of aliquots dedicated
clinic vs pathology centre
EDTA
Buffy coat 3 3 (3–3) 3 (3–3) 0.38
Plasma 10 12 (9–13) 11 (9–13) <0.01
Red cells 1 1 (1–1) 1 (1–1) *
ACD
Buffy coat 1 1 (1–1) 1 (1–1) *
Plasma 3 4 (3–5) 4 (3–5) 0.06
Li-Hep
Buffy coat 1 1 (1–1) 1 (1–1) 0.16
Plasma 3 4 (3–4) 3 (2–4) 0.01
Total 22 26 (21–29) 25 (20–28) <0.01
* Both groups have the same number of aliquots of this type.
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appointments and the phone reminders were to re-
sponse rates, since these were all part of the general
dedicated clinic protocol.
The trial examines response rates to biospecimen col-
lection and physical measurements among people
already participating in The 45 and Up Study. Similar to
most cohort studies, The 45 and Up Study is not
designed to be representative of the general population
[3]. Rather, it aims to provide a large cohort of indivi-
duals consenting to comprehensive and long term follow
up, with sufficient numbers in a range of population and
exposure groups to allow for valid internal comparisons.
The response rate to the main cohort was ~18%. The
overall response rate to the Link-Up Study of 33% could
be interpreted broadly as 6% of a general population
study taking part; comparable to the 9% seen in the UK
biobank, but less than other more localised community-
based cohort studies (e.g. EPIC Norfolk, Framingham).
The Link-Up Study aimed to test potential strategies
for large scale collection of biospecimens and physical
measurements from The 45 and Up Study participants.
While there was some limited promotion of the trial in
the annual newsletter distributed to 45 and Up Study
participants (via post or e-mail) and on the website of
The 45 and Up Study, there was no media promotion of
the trial or local publicity, or other strategies which
could potentially improve local participation. This is be-
cause the trial sought to explore methods that could be
used for The 45 and Up Study as a whole and there
would be potential difficulties doing this across the
~800,000 km2 of NSW, for a prolonged period of time. It
shows the response rate to a single ‘cold’ invitation to
take part, with reminders. There remains considerable
potential for improving response rates.
Dedicated clinics are considered the gold standard for
collection of biospecimens and biomarker data for cohort
studies, but are relatively expensive and time intensive to
establish. Funding must be sourced for infrastructure such
as premises and equipment and qualified staff must be
hired and trained; these costs will be greater when sam-
pling a geographically dispersed population. In addition to
cost, there are logistical implications associated with
establishing a clinic de novo. Once established, they can
generally only accept participants for a restricted time
period.
Collection through existing pathology centres has the
advantage of being easier to implement, and having a
broad network of collection locations that can be utilised
fairly rapidly. Disadvantages are that pathology centres
are less flexible and study design may need to be adapted
to this; for example, large numbers of fasting partici-
pants, designated appointment times and weekend col-
lection may not be able to be accommodated. While
response rates were 50% higher at dedicated clinics,
compared to commercial pathology centres, the total
weighted costs in this trial were 110% higher per invitee,
and 40% higher per final participant, at the dedicated
clinic versus the pathology centres.
The 45 and Up Study cohort is spread across NSW,
with over 50% in rural and regional areas. It would not
be practical to set up dedicated clinics to serve the entire
cohort, especially in sparsely populated areas. Hence, in
this case, a mixed method of collection is likely to be the
most practical.
It is generally assumed that more specialised staff,
experienced in the specific type of data collection
entailed, will collect data that is of higher quality than
less specialised or experienced staff. However, the as-
sumption has not, to our knowledge, been tested empiric-
ally in the setting of a biobank. The dedicated clinics
were set up for the sole purpose of collecting blood sam-
ples for research, in accordance with the trial protocol.
Conversely, the pathology centres provide a general com-
mercial service, collecting a range of biospecimens for
various purposes (predominantly clinical) and according
to different instructions. The pathology staff relied on
trial participants bringing the Pathology Request Form
with them, which provided specific instructions to the
phlebotomist. We found no material differences in the
physical measurements taken between the dedicated
clinics, with more specialised staff, and those at the path-
ology centres, and biospecimen yields were close to or
exceeded targets for the vast majority of participants.
This suggests that specialisation beyond the basic training
received by pathology centre staff for the purposes of this
trial did not appear to be accompanied by a discernable
improvement in data quality. If rolled out on a larger
scale, specific training of staff at every commercial path-
ology centre may be impractical and the incidence of
protocol deviations could potentially be greater, as there
would be less awareness of the study amongst staff in a
broad network of pathology centres. Hence, the findings
observed here may represent a best-case scenario.
Conclusions
For studies requiring the collection of biospecimens, use
of dedicated clinics set up specifically for the purpose of
the study, with designated appointment times, can in-
crease response rates when compared to using existing
pathology centres. However, each collection method has
advantages and disadvantages, including the fact that the
cost of collection through these dedicated clinics is
greater. Data quality and average biospecimen yield were
similar for the different types of data collection sites,
within this trial.
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